TruthArchive.ai - Related Video Feed

Bhutan and Portugal achieved successful vaccination coverage without relying on citizens understanding the science. Bhutan involved the religious establishment and considered the country's needs, resulting in fantastic coverage. Portugal appointed a retired army general who treated the campaign as a patriotic war, rallying the troops and leading Europe, if not the world, in vaccination efforts. It's important to note that no scientific explanations were provided in these campaigns.

By making the right investments, we can build a health system that stops outbreaks before they become global pandemics. A team of 3,000 disease experts called the Germ Team, managed by the WHO, will track suspicious disease clusters and share data with governments. Governments and pharmaceutical companies will collaborate to quickly produce diagnostics and vaccines on a large scale. An agreed protocol will ensure global sharing of results. The WHO and countries will work together to allocate these tools and ensure efficient delivery. To be prepared, the Germ Team will conduct drills with each country to assess readiness. The goal is to prevent diseases from becoming pandemics. For more information, check out the book "How to Prevent the Next Pandemic?"

CRISPR, a lab technique, can alter mosquito DNA to decrease their population or prevent them from carrying parasites. Discussions are underway with African countries to determine the necessary tests and trials before implementing this technique. Although it will take several years to obtain country approvals, the potential to reduce mosquito populations and eliminate malaria locally is promising. The speaker even brought some mosquitoes to the auditorium to provide firsthand experience. They emphasize that it is unfair for only poor people to face this issue.

Scientists are increasingly skeptical about the feasibility and safety of developing an AIDS vaccine. The concern lies in the lengthy testing process required to ensure its effectiveness and potential risks. Initially, a small group of individuals would be administered the vaccine, and if no adverse effects are observed after a year, it would be expanded to 500 people. After another year without complications, the vaccine would be given to thousands. However, the worry is that it could take up to 12 years for any serious issues to arise. This uncertainty raises doubts about the viability of creating an AIDS vaccine.

There is a technique called CRISPR in the lab that can manipulate mosquito DNA to reduce their population or eliminate the disease they carry. Discussions are ongoing with African countries to determine the necessary tests and trials before implementing this solution. However, obtaining country approvals will take several years. Despite the time frame, the potential of reducing mosquito population and eradicating the disease locally makes this approach highly promising.

Doctors in Australia have found a potential cure for the coronavirus using a drug called Ivermectin. This medicine, which is already FDA approved and on the World Health Organization's list of essential medicines, has been shown to kill the virus in less than 48 hours. It is safe, widely available, and inexpensive, costing just 12 cents for a course of treatment. When combined with two other drugs, doxycycline and zinc, Ivermectin has been found to be highly effective in treating the virus. Doctors in Broward County, Florida have reported a near 100% success rate in curing coronavirus patients using Ivermectin. However, it remains to be seen how other medical experts will respond to this discovery.

The situation has been horrific, leading to a shift in research and development budgets. Current vaccines primarily focus on improving individual health but only slightly reduce transmission. There is a need for a new approach to vaccine development that effectively blocks transmission.

The most urgent invention is a COVID-19 vaccine, which teaches the immune system about the pathogen, specifically the coronavirus and its spike protein. The spike protein grabs cells and causes them to make billions of copies of the virus. Vaccines expose the body to something that looks like the virus, prompting the body to create antibodies to kill it. Vaccine creation usually involves injecting part of the virus's shape. This can be the whole virus, attenuated, or killed. Often, just a piece of the virus or the spike is used, eliminating the risk of causing disease. A promising new method is the RNA vaccine, which uses instructions to make the spike's shape. The Gates Foundation and partners are exploring these efforts. Creating a new vaccine typically takes at least 5 years, but there is optimism that a vaccine will be available in the next 18 months, produced in volume, and accessible worldwide, which will end the pandemic.

Creating mRNA is easy, cheap, and scalable. In the next 5 years, we aim to improve stability and cost, allowing for global vaccine production. mRNA will be explored for diseases like HIV, malaria, and TB with various approaches. The Gates Foundation and other global health organizations will support mRNA vaccine development.

We ensure there is enough capacity and competition for vaccines, leading to lower prices and the development of new vaccines. This includes vaccines for TB, malaria, HIV, and even COVID-19. To improve vaccines, we aim for longer duration and broader coverage, and plan to replace needles with patches. The pandemic has shown that we have not invested enough in these innovations. Our partners in India play a crucial role in achieving these breakthrough products.

We should not return to our complacency about pandemics. In the future, we can have mega testing platforms that are quick, inexpensive, and can test 20% of the population weekly. Monoclonal antibodies show promise in reducing death rates by 80%. The mRNA platform will make vaccine development faster, easier, and cheaper. To prevent future pandemics, we need a global alert system to detect disease outbreaks worldwide. We also need a group of infectious disease responders, like pandemic firefighters, who can quickly build capacity and respond to new pathogens. This investment is like the best insurance policy the world could buy.

We should not return to our complacency about pandemics. In the future, we can have mega testing platforms that are quick, inexpensive, and can test 20% of the population weekly. Monoclonal antibodies are a promising treatment that can reduce death rates by 80%. The development of new vaccines will be faster, easier, and cheaper thanks to the mRNA platform. To prevent future pandemics, we need a global alert system and a group of infectious disease responders who can act quickly. This investment is like the best insurance policy the world could buy.

The majority of men worldwide are uncircumcised, with Americans being the main group practicing circumcision. Some argue that there are medical reasons for circumcision, such as preventing UTIs. However, others question the medical industrial complex and its motives. Research suggests that circumcision may have long-term effects on the brain, resembling PTSD. Concerns about social acceptance and being the only uncircumcised person in the locker room are also raised. The circumcision rate in the US has decreased to around 50%. The speaker points out that men are the main proponents of this practice. The lack of a national debate on the topic is criticized, and the financial incentive behind circumcision is highlighted. It is noted that many people are unaware that there is no anesthesia during circumcision.

The most urgent invention is a COVID-19 vaccine, which teaches the immune system about the pathogen, specifically the coronavirus and its spike protein. The spike protein grabs cells and causes them to make billions of copies of the virus. Vaccines expose the body to something that looks like the virus, prompting the body to create antibodies to kill it. Vaccine creation usually involves injecting part of the virus's shape. This can be the whole virus, attenuated, or killed, or just a piece of the virus or the spike. A promising new method is the RNA vaccine, which uses RNA and DNA to provide instructions to make the spike shape. The Gates Foundation and partners are exploring these efforts. Creating a new vaccine typically takes at least 5 years, but there is optimism that a vaccine will be available in the next 18 months, produced in volume, and accessible to everyone, which is how the pandemic will end.

Over the past 20 years, $10 billion has been invested in vaccinations, resulting in a remarkable return on investment of 20 to 1. This economic benefit far surpasses other options, such as investing in the S&P 500, which would have yielded around $17 billion with reinvested dividends. However, the impact of vaccinations is estimated to be even greater, potentially reaching $200 billion.

In the next 5 years, we can easily and inexpensively produce mRNA, which is the key to its success. We just need to work on improving the stability, cost, and scalability of lipid nanoparticles. Once we achieve that, we can establish factories worldwide to manufacture affordable vaccines within a short time frame. We plan to use mRNA technology for diseases like HIV, malaria, and tuberculosis, with different approaches for each. The Gates Foundation and other organizations focused on global health will support our efforts to develop these missing vaccines using mRNA.

Developing a vaccine is crucial to controlling the pandemic. Normally, it takes about five years to create a new vaccine, including testing for safety and effectiveness. However, efforts are being made to compress this timeline to around 18 months. The RNA platform shows promise in speeding up production. Ensuring a vaccine's effectiveness and safety, especially for older individuals, is challenging. We must avoid compromising safety while increasing efficacy. Decision-making regarding the use of a new vaccine will be based on limited data to expedite progress. Supporting the development of the most promising candidates, building production facilities, and conducting safety testing require a global collaborative effort. Our foundation is heavily involved in funding vaccines, including for developing countries. It's encouraging to see various medications emerging, such as Moderna, CureVac, Stamovi, and Logovac, which require investment.

With cooperation, generosity, and innovation, a partnership with BioNTech aims to create vaccines for TB, HIV, and malaria. If the right actions are taken over the next 20 years, most countries can escape the poverty trap and become self-sufficient. Accelerating this process is a positive goal that many leaders are engaged in. However, due to cuts in aid budgets, including Germany's, approximately 30% less funding will be raised for vaccines compared to five years ago.

Speaker 0: It is a report that concludes that The United States official foreign policy signed into law in 1975 by president Ford, and when I say signed into law, it's called a presidential directive, is the reduction of population in 12 foreign twelve twelve specific foreign countries. Not the control of population, the reduction of population. And so it explains the ways we're gonna do this is through medicalizing birth control, never was before. You didn't need a doctor to get a condom, and to go around and talk to villages everywhere and say, you want a reproductive health freedom, don't you? You know what most women want on the planet Earth? Babies. They're they're not looking for reproductive health freedom was a term for have fewer babies. Right? There is a very potent move in official US foreign policy to reduce population in other countries. Now why? Philippines or or Indonesia. Why? They state it directly in the Kissinger report because it's classified. They wanted to reduce those countries' development so that they wouldn't need their own raw materials because we want them, the metals, etcetera. It is dark as shit, the Kissinger reports. It's not and it's not classified anymore. You can, you know, ask chat GPT about it to give you quotes from it. And so this whole business of population reduction is now another third rail I'm stepping on. Right? Nobody wants it. What are you you're nuts. No. A lot of people want it. A lot of people believe, obviously, Bill Gates, that 8,000,000,000 people was the number where we must turn it around, which is where we are supposedly now. And the Kissinger report, I was a kid. I didn't write it. I didn't make it up. You can find it on Wikipedia. It's a real thing. And all the presidential directives that came from it. Would these countries like the idea that we show up and we say, hey. We've got a new tetanus vaccine for you, but it happens to also have in it secretly something that will reduce fertility in your women as we did in India, as we did in Peru. In both India and Peru, we also did forced sterilization surgeries. US paid for them. True story. Speaker 1: So the the one vaccine was the DTP vaccine. Is that what it was? Speaker 0: The the one I'm talking about. The the Speaker 1: the The one that had h c g in it? It was just tetanus. But there was a vaccine that was in Bobby Kennedy's book Yeah. Where they were talking about women in Africa, where they were unknowingly given Yeah. This vaccine against That's that's diphtheria, tetanus, and Speaker 0: Well, it was the tetanus part Right. That that they were that they were pitching. And by the way, tetanus is a challenge in those countries more than it is in The United States. But, yeah, they were call they were naming them wellness drugs. Speaker 1: And they had h c g Speaker 0: in it. That's correct. Speaker 1: And that h c g, and they were more administered to women than they were to men. Speaker 0: Oh, of course. And they were five. They would administer administer five of the injections. Speaker 1: And they did it under this the guys were the the the narrative was that women were more vulnerable. So you have to give the vaccination to women. Yeah. And it was preventing them from getting pregnant. Speaker 0: It was preventing them from getting pregnant, and they had World Health Organization, which basically has this as a mission. Man, I wish they would sue me for saying this, but they they have this as a mission, which is population reduction from the beginning. They had worked on that HCG. Speaker 1: There's Gates famously, Speaker 0: of course, Speaker 1: in the speech saying Speaker 0: We can do that with vaccines. Speaker 0: Yeah. By the way, in the Kissinger report, for those of you not seeing this and only hearing it, that was me drinking my pause was me drinking water. I did not have a stroke. In the Kissinger report, they list the strategies and how much funding they'll give to each strategy. One of the strategies is to medicalize birth control, meaning have trusted people in the villages, etcetera. Another one is to pay young men to have a vasectomy. Just outright pay you know, write a check-in villages so they get $60 and they get a nice weekend of buying beer, but they never have kids. But another one of them is injections that reduce that temporarily reduce male fertility. Now here's an interesting thing about that one. It's in the Kissinger report. Injections that temporarily reduce male fertility. The COVID vaccine reduces sperm count in men for three months admitted by Fauci. It's not a secret. But the CDC's response was, yeah, but it's only for three months. And But they were asking us to take one every fucking three months. Well, also the miscarriages. Miscarriages and stillbirths. My point is that it's no it's no surprise that these persistent thoughts that I think good people believe meaning, I think there are good people who believe that population reduction is important. The fact is, of course, that now we are barely at replacement, you know, at replacement value right now in terms of many populations.

Global health initiatives can save lives for under $2,000 each, which is a worthwhile investment. Progress is being made in developing tools for Africa, such as extending the duration of treatments or enabling self-administration at home. These innovations empower women and attract specific investors. It's crucial to create a diverse portfolio rather than focusing on a single drug, as this reduces the risk of failure. The pharmaceutical industry is becoming more adept at minimizing early-stage risks, ensuring that the projects selected for funding have a high probability of success in later phases.

“And we will have new vaccines. We'll have a, TB vaccine, malaria vaccine, HIV vaccine, and even the things like COVID vaccines.” The speaker envisions vaccines for TB, malaria, HIV, and COVID, with longer duration and broader coverage. “We need to make them have longer duration, more coverage, and we're gonna change instead of using the needle to use a little patch.” The plan includes longer-lasting protection and a switch from needle injections to patch delivery. “So the pandemic really highlighted that we've been underinvested in those innovations, and, you know, our partners in India are are part of how we're gonna get these breakthrough products done.” The pandemic is cited as underscoring underinvestment, with India-based partners playing a role in bringing breakthrough products to fruition.

USAID was offering free circumcisions globally but charging US taxpayers excessively. I updated my X account with a joke about circumcision discounts, now at 50%. It's about competing for business. It's a crypto joke. My humor is underappreciated. I wish the last could have pushed circumcision at a 50% discount.

The most urgent invention is a COVID-19 vaccine, which teaches the immune system about the pathogen, specifically the coronavirus and its spike protein. The spike protein grabs cells and causes them to make billions of copies of the virus. Vaccines expose the body to something that looks like the virus, prompting the body to create antibodies to kill it. Vaccine creation usually involves injecting part of the virus's shape. This can be the whole virus (attenuated), a killed virus, or just a piece of the virus, like the spike. A promising new method is the RNA vaccine, which uses instructions to make the spike's shape. The Gates Foundation and partners are exploring these efforts. Creating a new vaccine typically takes at least 5 years, but there is optimism that a vaccine will be available in the next 18 months, produced in volume, and accessible worldwide, which is how the pandemic will end.

We only have one old and ineffective licensed vaccine for tuberculosis. To improve this, we aim to use the experience gained from developing effective platforms during the COVID-19 pandemic to create a new and effective tuberculosis vaccine. Today, we received unprecedented commitments from member states, partners, and donors to invest in this initiative. We believe that this new vaccine could be a game-changer. We are inspired and eager to support all stakeholders and work together with them to make this happen.

New vaccines for tuberculosis, malaria, HIV, and COVID-19 are being developed. These vaccines aim to have longer-lasting effects and wider coverage. In addition, instead of using needles, a patch will be used for administration. The COVID-19 pandemic has brought attention to the fact that we have not invested enough in these innovative advancements.